We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
-6.28%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$34.5B
AUM Growth
-$9.22B
(-21%)
Cap. Flow
-$7.24B
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
18.89%
Holding
8,640
New
1,474
Increased
2,846
Reduced
2,852
Closed
1,160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arm
ARM
|
+$49.7M |
| 2 |
Robinhood
HOOD
|
+$25.4M |
| 3 |
Newmont
NEM
|
+$24.6M |
| 4 |
NextEra Energy
NEE
|
+$24.3M |
| 5 |
Micron Technology
MU
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$32.9M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
GXO Logistics
GXO
|
+$30.4M |
| 4 |
Wells Fargo
WFC
|
+$29.7M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.54% |
| 2 | Financials | 0.95% |
| 3 | Healthcare | 0.88% |
| 4 | Consumer Discretionary | 0.66% |
| 5 | Industrials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6776
PUT
Cue Biopharma
CUE
$114M
| $3.64K | ﹤0.01% |
133
-67
| -34% | -$2.49K |
|
6777
ProShares Ultra 20+ Year Treasury
UBT
$57.9M
| $3.63K | ﹤0.01% |
200
| – | – |
|
6778
PUT
NetSol Technologies
NTWK
$50.6M
| $3.63K | ﹤0.01% |
1,500
-2,000
| -57% | -$5.07K |
|
|
CVAC
6779
PUT
DELISTED
CureVac
CVAC
| $3.6K | ﹤0.01% |
1,300
-44,700
| -97% | -$156K |
|
6780
CALL
Werewolf Therapeutics
HOWL
$19.3M
| $3.6K | ﹤0.01% |
3,700
-9,100
| -71% | -$11.9K |
|
|
GGRP
6781
PUT
Glimpse Group
GGRP
$18.7M
| $3.6K | ﹤0.01% |
3,100
-15,400
| -83% | -$25.3K |
|
6782
CALL
Afya
AFYA
$1.27B
| $3.59K | ﹤0.01% |
200
| – | – |
|
6783
CALL
Protalix BioTherapeutics
PLX
$198M
| $3.58K | ﹤0.01% |
1,400
-600
| -30% | -$1.43K |
|
6784
ADT
ADT
$5.58B
| $3.58K | ﹤0.01% |
+440
| New | +$3.32K |
|
6785
PUT
JELD-WEN Holding
JELD
$164M
| $3.58K | ﹤0.01% |
600
+300
| +100% | +$2.23K |
|
6786
PUT
Puma Biotechnology
PBYI
$454M
| $3.55K | ﹤0.01% |
+1,200
| New | +$3.76K |
|
|
INGM
6787
CALL
Ingram Micro Holding
INGM
$6.55B
| $3.55K | ﹤0.01% |
+200
| New | +$4.26K |
|
6788
PUT
Acumen Pharmaceuticals
ABOS
$176M
| $3.52K | ﹤0.01% |
3,200
-35,100
| -92% | -$50.1K |
|
6789
China Automotive Systems
CAAS
$133M
| $3.51K | ﹤0.01% |
795
| – | – |
|
6790
PUT
Future Fuel
FF
$223M
| $3.51K | ﹤0.01% |
+900
| New | +$4.33K |
|
6791
CALL
KNOT Offshore Partners
KNOP
$366M
| $3.49K | ﹤0.01% |
500
-800
| -62% | -$4.62K |
|
6792
CALL
Enact Holdings
ACT
$6.73B
| $3.48K | ﹤0.01% |
100
-11,700
| -99% | -$391K |
|
6793
CALL
Champions Oncology
CSBR
$72.1M
| $3.47K | ﹤0.01% |
+400
| New | +$4.05K |
|
6794
MoneyHero
MNY
$40.6M
| $3.47K | ﹤0.01% |
4,504
-2,004
| -31% | -$1.93K |
|
6795
PTC Therapeutics
PTCT
$6.12B
| $3.46K | ﹤0.01% |
68
-393
| -85% | -$19.6K |
|
6796
CALL
Arena Group
AREN
$83.8M
| $3.46K | ﹤0.01% |
+2,000
| New | +$2.93K |
|
6797
CALL
Envista
NVST
$4.52B
| $3.45K | ﹤0.01% |
+200
| New | +$3.89K |
|
|
6798
PUT
Envista
NVST
$4.52B
| $3.45K | ﹤0.01% |
200
-1,100
| -85% | -$21.4K |
|
6799
Direxion Daily MSCI Mexico Bull 3X ETF
MEXX
$20.3M
| $3.45K | ﹤0.01% |
314
| – | – |
|
6800
Marcus & Millichap
MMI
$1.19B
| $3.44K | ﹤0.01% |
100
| – | – |
|
Similar funds
SCP
Group One Trading's Q1 2025 Portfolio in Review
As of Q1 2025, Group One Trading held 8,640 positions worth $34.5B, down 21% from $43.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Group One Trading withdrew a net $7.24B in Q1 2025, closing 1,160 positions and reducing 2,852 holdings. Its most notable exit was Madrigal Pharmaceuticals, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 1.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Group One Trading opened a new position in Arm worth $38M.
- Group One Trading's largest Q1 2025 buy was Arm: 356,137 shares worth $38M.
- Group One Trading added most to Robinhood in Q1 2025, an estimated $25.4M increase.
- Group One Trading's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $31M.
- Group One Trading fully exited Madrigal Pharmaceuticals in Q1 2025, selling an estimated $32.9M.
- Group One Trading's ten largest holdings make up 19% of its $34.5B portfolio in Q1 2025.
- Group One Trading opened 1,474 new positions and closed 1,160 in Q1 2025.
- Group One Trading's portfolio value fell 21% quarter-over-quarter to $34.5B.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.